Susan Rodriguez
CIK 1812511 · CCSO · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.33M
Companies
4
Total Filings
37
Lifetime Open-Market Net
-$274.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNPR | CCSO | — | $109.09 | — | $0 | 1 | 2026-03-04 |
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Chief Operating Officer | — | $21.64 | — | $0 | 2 | 2026-02-12 |
| HRTX | Director | 87,180 | $0.49 | $42.4K | $0 | 5 | 2025-02-04 |
| ARDX | Chief Commercial Officer | 449,092 | $5.08 | $2.28M | -$274.7K | 22 | 2024-05-23 |
Recent Filings · Page 2 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-20 | — | Grant (A) | +42,106 | $0 | |
| 2024-06-13 | ARDX | Notice (144) | −200 | -$1.4K | EDGAR |
| 2024-05-23 | ARDX | Sell (S) | −6,703 | -$52.4K | EDGAR |
| 2024-02-22 | ARDX | Sell (S) | −6,928 | -$60.6K | EDGAR |
| 2024-01-19 | HRTX | Grant (A) | +13,948 | $0 | EDGAR |
| 2024-01-18 | ARDX | Grant (A) | +112,750 | $0 | EDGAR |
| 2023-11-22 | ARDX | Sell (S) | −4,714 | -$20.6K | EDGAR |
| 2023-08-23 | ARDX | Sell (S) | −4,733 | -$16.8K | EDGAR |
| 2023-05-25 | ARDX | Sell (S) | −4,711 | -$17.2K | EDGAR |
| 2023-03-02 | ARDX | Sell (S) | −5,586 | -$16.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.